z-logo
open-access-imgOpen Access
Transcriptional Studies on a Streptomyces clavuligerus oppA2 Deletion Mutant: N -Acetylglycyl-Clavaminic Acid Is an Intermediate of Clavulanic Acid Biosynthesis
Author(s) -
Rubén Álvarez-Álvarez,
Antonio RodríguezGarcía,
Yolanda Martínez-Burgo,
Juan F. Martı́n,
Paloma Liras
Publication year - 2018
Publication title -
applied and environmental microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.552
H-Index - 324
eISSN - 1070-6291
pISSN - 0099-2240
DOI - 10.1128/aem.01701-18
Subject(s) - streptomyces clavuligerus , clavulanic acid , mutant , biochemistry , biology , permease , gene , biosynthesis , chemistry , antibiotics , amoxicillin
Theoppa2 gene encodes an oligopeptide permease essential for the production of clavulanic acid. A transcriptomic analysis ofS. clavuligerus ΔoppA2 ::aac in comparison to the parental strainS. clavuligerus ATCC 27064 is reported. The lack of OppA2 results in different expression of 233 genes, including genes for proteases and genes for transport systems. The expression of the clavulanic acid genes in theoppA2 mutant is not significantly affected, but the genes for holomycin biosynthesis are strongly upregulated, in agreement with the higher holomycin production by this strain. TheoppA2 -mutant is known to releaseN -acetylglycyl-clavaminic acid to the broth. Cosynthesis assays using non-clavulanic acid-producing mutants showed that the addition of pureN -acetylglycyl-clavaminic acid to mutants in which clavulanic acid formation was blocked resulted in the recovery of clavulanic acid production, but only in mutants blocked in the early steps of the pathway. This suggests thatN -acetylglycyl-clavaminic acid is a previously unknown late intermediate of the clavulanic acid pathway.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom